Events

MEDx Café

Wednesdays | 10:30 a.m.-12:00 p.m.

An informal time set aside by MEDx leadership for discussions with faculty, staff and students. Learn more about MEDx, an initiative between the School of Medicine and the Pratt School of Engineering, and get help finding collaborators, resources, and connections. To chat, contact Donna Crenshaw directly at donna.crenshaw@duke.edu or 919-660-1915.

There are no MEDx Café meetings currently scheduled. Please check back during the academic year.

Upcoming Events

Startup Sales and Marketing: Even the Greatest Products Don't Sell Themselves

Tuesday, April 20

7:00 pm to 10:00 pm Online

Presenter: Chris Morrison

You can develop a best in class medical device and the world will NOT "make a beaten path to your door." Chris will challenge you to undertake a disciplined approach to develop the market, educate, and sell your concept to deliver medical innovation and improve patients' lives. While worthwhile endeavors start with a mission and vision, market intelligence, objectives, strategies and tactics still rule the day. From selling your idea to investors to obtaining market access, product trial, luminary advocacy, sales, social evidence, coverage and growth, the process requires disciplines, an open mind, ability to pivot and perseverance. We will share examples of success and of great products that failed to achieve their potential and uncover the reasons. You will work to develop your own product go-to-market strategy and have opportunity for questions. Zoom link provided upon registration. Registration: https://duke.qualtrics.com/jfe/form/SV_cRVqPR6um6l4dIF

Chris Morrison headshot

The Unjamming Transition (UJT) is Fundamental to Wound Healing, Embryonic Development, and Cancer Invasion

Thursday, April 22

12:00 pm to 1:00 pm Register Here

Presenter: Jeffrey J. Fredberg, Ph.D

Dr. Jeffrey Fredberg's laboratory investigates physical processes expressed by the eukaryotic cell, such as its deformability, contractility, malleability, and motility. His team turned attention more recently from the single cell in isolation to the cellular collective as it might pertain, for example, to disruption of the bronchial epithelial layer in asthma or tumor invasion in breast cancer. To probe these physical processes at the levels of the single cell and the cellular collective, his team developeda series of novel microscale technologies that now include magnetic twisting cytometry, Fourier-transform traction microscopy, monolayer traction microscopy, and monolayer stress microscopy. Using this suite of technologies, the team was first to show that cells comprising an epithelial collective can jam much as do coffee beans that become jammed a chute. Or instead, they can unjam and migrate, invade and spread. Taken together, this body of work has illuminated relevant but poorly understood physical processes that underlie asthma, wound healing, development, and cancer. Dr. Fredberg has served on the scientific advisory committee of the Parker B. Frances Foundation, as a full time member on three standing NIH study sections (RAP/RIBT, program project HLBP, T32 institutional training mechanism NITM), and on two NIH committees (NSF/NIH interagency panel on Research at the Interface of Life and Physical Sciences; and the Study Section Boundary Team, Pulmonary Sciences IRG

Jeffrey J. Fredberg, Ph.D

Advancing Personalized Medicine Through Inclusive Biomedical Research

Thursday, April 22

10:00 pm to 11:30 pm Register Here

Presenter: Geoffrey S. Ginsburg

PMC is pleased to present a 90-minute virtual discussion titled Advancing Personalized Medicine Through Inclusive Biomedical Research. Moderated by PMC Founder and Director of the Duke Center for Applied Genomics and Precision Medicine Geoffrey S. Ginsburg, M.D., Ph.D., the program features a diverse panel of leaders from across the health care spectrum who are contributing to the development of research programs in the public and private sectors. By uncovering the sociocultural, behavioral, and systemic factors that converge to perpetuate inequities in research participation and outcomes, the program is designed to inform a PMC report that enhances our understanding of the strategies we can adopt to facilitate the emergence of a more inclusive biomedical research enterprise. 10:00 a.m. ET | Understanding the Landscape for Advancing Personalized Medicine Through Inclusive Biomedical Research 10:50 a.m. ET | Promoting Diversity, Equity, and Inclusion in Research and Clinical Settings: Opportunities and Challenges

Geoffrey Ginsburg, MD, PhD